CIK 0001736243
- Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | Sailer Carl Director | Grant or award · Stock Option | +2,150 | 2,150 | ||
| 2025-01-06 | Sailer Carl Director | Purchase | +24,631 | $1.02 | $25K | 137,183 |
| 2025-01-06 | Sailer Carl Director | Purchase · Warrants for Common Stock | +24,631 | 24,631 | ||
| 2024-06-17 | Sailer Carl Director | Grant or award · Stock Option | +12,000 | 12,000 | ||
| 2024-01-19 | Sailer Carl Director | Option exercise | +19,737 | $3.55 | $70K | 112,552 |
| 2024-01-19 | Sailer Carl Director | Option exercise · Warrants for Common Stock | −19,737 | 0 | ||
| 2023-06-15 | Sailer Carl Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2022-07-27 | Sailer Carl Director | Purchase | +19,737 | $3.80 | $75K | 92,815 |
| 2022-07-27 | Sailer Carl Director | Purchase · Warrants for Common Stock | +19,737 | 19,737 | ||
| 2022-07-27 | Sailer Carl Director | Purchase · Warrants for Common Stock | +19,737 | 19,737 | ||
| 2021-11-23 | Sailer Carl Director | Purchase | +5,161 | $4.84 | $25K | 73,078 |
| 2021-07-01 | Sailer Carl Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2021-06-29 | Sailer Carl Director | Purchase | +12,500 | $6.00 | $75K | 67,917 |
Page 1 of 1 · 13 trades